Tumor-suppressive microRNA-1291 directly regulates glucose transporter 1 in renal cell carcinoma.
Ontology highlight
ABSTRACT: Our recent studies of microRNA (miRNA) expression signatures demonstrated that microRNA-1291 (miR-1291) was significantly downregulated in renal cell carcinoma (RCC) clinical specimens and was a putative tumor-suppressive miRNA in RCC. The aim of the present study was to investigate the functional significance of miR-1291 in cancer cells and to identify novel miR-1291-mediated cancer pathways and target genes in RCC. Expression of miR-1291 was significantly downregulated in RCC tissues compared with adjacent non-cancerous tissues. Restoration of mature miR-1291 in RCC cell lines (A498 and 786-O) revealed significant inhibition of cell proliferation, migration and invasion, suggesting that miR-1291 functioned as a tumor suppressor. To identify miR-1291-mediated molecular pathways and target
SUBMITTER: Yamasaki T
PROVIDER: S-EPMC7654250 | biostudies-literature | 2013 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA